Effects of 5HT1A Activation on Gating Profile Following 5HT Depletion in Rats Lacking Social Attachment Since Weanling

Psychiatry Investigation
Yueh-Ming TaiYia-Ping Liu

Abstract

Central 5-HT1A receptor is involved in the modulation of sensorimotor gating function. However, its precise role is not clearly defined in developmentally social deprived (isolation rearing, IR) rats featured with impaired sensorimotor gating ability. We therefore aimed to examine the effects of 5HT1A activation on acoustic startle response (ASR) and prepulse inhibition (PPI) in IR rats in a condition of compromised presynaptic 5-HT functions. Social control (SOC) and IR rats received an intracerebraoventricular (ICV) injection of 5-HT depletor, 5,7-DHT. Seven days later rats entered a protocol of 8-OH-DPAT, a 5-HT1A agonist, in which locomotor activity, ASR and PPI and their tissue levels of 5-HT were measured. Our results found that both IR and 5,7-DHT decreased the tissue concentration of 5-HT. IR-induced hyperactivity and gating impairment were unaffected by 5-HT depletion. 8-OH-DPAT strengthened the ASR in IR but not SOC rats and the drug-reduced PPI could be adjusted by 5,7-DHT pretreatment. 8-OH-DPAT at 100 μg/kg enhanced PPI in 5-HT-depleted SOC rats. However for IR rats, 8-OH-DPAT strengthened PPI in sham rats but downgraded it in depletion condition. The integrity of central 5-HT system is important to 5-HT1A-modulate...Continue Reading

References

Jan 1, 1976·Annual Review of Pharmacology and Toxicology·H G Baumgarten, A Björklund
Jan 1, 1991·Psychopharmacology·I K WrightC A Marsden
Feb 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·L S WilkinsonT W Robbins
Jan 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·E C AzmitiaP M Whitaker-Azmitia
Apr 29, 1998·Brain Research. Molecular Brain Research·S RasmusonA H Mohammed
Feb 22, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·P J FletcherT L Sills
Jan 25, 2003·Pharmacology, Biochemistry, and Behavior·André RexHeidrun Fink
Jul 31, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Snezana KusljicMaarten van den Buuse
Jan 26, 2006·Journal of Neuroscience Research·Andre Rex, H Fink
Feb 24, 2007·Progress in Neurobiology·Christian P MüllerMaria A De Souza Silva
Nov 13, 2007·Journal of Shoulder and Elbow Surgery·Damian McClelland, Anastasios Paxinos
Mar 15, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yia-Ping LiuChe-Se Tung
Dec 20, 2011·Pharmacological Reports : PR·Paulina KołomańskaRoman Stefański
Jun 7, 2015·Medical Hypotheses·Yu-Yin YangYia-Ping Liu

❮ Previous
Next ❯

Citations

Oct 21, 2021·Acta Neuropsychiatrica·Bilgin KaygisizFatma Sultan Kilic

❮ Previous
Next ❯

Software Mentioned

LAB
SR
Med
SPSS
Associates

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.